Lisa K. Torres

Lisa K. Torres

Auto-generated profile, based on publicly available information

Lisa K. Torres

Weill Cornell Medicine

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2024 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
AGAnthony C. Gordon
Anthony C. Gordon
NANarges Alipanah-Lechner
Narges Alipanah-Lechner
LBLieuwe Bos
Lieuwe Bos
JDJose Dianti
Jose Dianti
JDJanet V. Diaz
Janet V. Diaz
CCCarolyn S. Calfee
Carolyn S. Calfee
Critical care uses syndromic definitions to describe patient groups for clinical practice and research. There is growing recognition that a “precision medicine” approach is required and that integrated biologic and physiologic data identify reproducible subpopulations that may respond differently to treatment. This article reviews the current state of the field and considers how to successfully transition to a precision medicine approach. To impact clinical care, identification of subpopulations must do more than differentiate prognosis. It must differentiate response to treatment, ideally by defining subgroups with distinct functional or pathobiological mechanisms (endotypes). There are now multiple examples of reproducible subpopulations of sepsis, acute respiratory distress syndrome, and acute kidney or brain injury described using clinical, physiological, and/or biological data. Many of these subpopulations have demonstrated the potential to define differential treatment response, largely in retrospective studies, and that the same treatment-responsive subpopulations may cross multiple clinical syndromes (treatable traits). To bring about a change in clinical practice, a precision medicine approach must be evaluated in prospective clinical studies requiring novel adaptive trial designs. Several such studies are underway, but there are multiple challenges to be tackled. Such subpopulations must be readily identifiable and be applicable to all critically ill populations around the world. Subdividing clinical syndromes into subpopulations will require large patient numbers. Global collaboration of investigators, clinicians, industry, and patients over many years will therefore be required to transition to a precision medicine approach and ultimately realize treatment advances seen in other medical fields.

16 April 2021 in Thorax
Verified
Journal Article
Closed access
PDF file
LTLisa K Torres
Lisa K Torres
KHKatherine L Hoffman
Katherine L Hoffman
COClara Oromendia
Clara Oromendia
IDIvan Diaz
Ivan Diaz
JHJohn S Harrington
John S Harrington
ISIlias I. Siempos
Ilias I. Siempos
Background Although acute respiratory distress syndrome (ARDS) is associated with high mortality, its direct causal link with death is unclear. Clarifying this link is important to justify costly research on prevention of ARDS. Objective To estimate the attributable mortality, if any, of ARDS. Design First, we performed a systematic review and meta-analysis of observational studies reporting mortality of critically ill patients with and without ARDS matched for underlying risk factor. Next, we conducted a survival analysis of prospectively collected patient-level data from subjects enrolled in three intensive care unit (ICU) cohorts to estimate the attributable mortality of critically ill septic patients with and without ARDS using a novel causal inference method. Results In the meta-analysis, 44 studies (47 cohorts) involving 56 081 critically ill patients were included. Mortality was higher in patients with versus without ARDS (risk ratio 2.48, 95% CI 1.86 to 3.30; p<0.001) with a numerically stronger association between ARDS and mortality in trauma than sepsis. In the survival analysis of three ICU cohorts enrolling 1203 critically ill patients, 658 septic patients were included. After controlling for confounders, ARDS was found to increase the mortality rate by 15% (95% CI 3% to 26%; p=0.015). Significant increases in mortality were seen for severe (23%, 95% CI 3% to 44%; p=0.028) and moderate (16%, 95% CI 2% to 31%; p=0.031), but not for mild ARDS. Conclusions ARDS has a direct causal link with mortality. Our findings provide information about the extent to which continued funding of ARDS prevention trials has potential to impart survival benefit. PROSPERO Registration Number CRD42017078313

15 February 2021 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
DPDavid R. Price
David R. Price
KHKatherine L. Hoffman
Katherine L. Hoffman
COClara Oromendia
Clara Oromendia
LTLisa K. Torres
Lisa K. Torres
ESEdward J. Schenck
Edward J. Schenck
ISIlias I. Siempos
Ilias I. Siempos

1 November 2021 in Annals of the American Thoracic Society
Verified
Journal Article
Closed access
ESEdward J. Schenck
Edward J. Schenck
KHKatherine L. Hoffman
Katherine L. Hoffman
COClara Oromendia
Clara Oromendia
ESElizabeth Sanchez
Elizabeth Sanchez
EFEli J. Finkelsztein
Eli J. Finkelsztein
TCThomas R. Campion
Thomas R. Campion
Rationale: The Sequential Organ Failure Assessment (SOFA) tool is a commonly used measure of illness severity. Calculation of the respiratory subscore of SOFA is frequently limited by missing arterial oxygen pressure (PaO2) data. Although missing PaO2 data are commonly replaced with normal values, the performance of different methods of substituting PaO2 for SOFA calculation is unclear. Objectives: The study objective was to compare the performance of different substitution strategies for missing PaO2 data for SOFA score calculation. Methods: This retrospective cohort study was performed using the Weill Cornell Critical Care Database for Advanced Research from a tertiary care hospital in the United States. All adult patients admitted to an intensive care unit (ICU) from 2011 to 2019 with an available respiratory SOFA score were included. We analyzed the availability of the PaO2/fraction of inspired oxygen (Fi O2) ratio on the first day of ICU admission. In those without a PaO2/Fi O2 ratio available, the ratio of oxygen saturation as measured by pulse oximetry to Fi O2 was used to calculate a respiratory SOFA subscore according to four methods (linear substitution [Rice], nonlinear substitution [Severinghaus], modified respiratory SOFA, and multiple imputation by chained equations [MICE]) as well as the missing-as-normal technique. We then compared how well the different total SOFA scores discriminated in-hospital mortality. We performed several subgroup and sensitivity analyses. Results: We identified 35,260 unique visits, of which 9,172 included predominant respiratory failure. PaO2 data were available for 14,939 (47%). The area under the receiver operating characteristic curve for each substitution technique for discriminating in-hospital mortality was higher than that for the missing-as-normal technique (0.78 [0.77–0.79]) in all analyses (modified, 0.80 [0.79–0.81]; Rice, 0.80 [0.79–0.81]; Severinghaus, 0.80 [0.79–0.81]; and MICE, 0.80 [0.79–0.81]) (P < 0.01). Each substitution method had a higher accuracy for discriminating in-hospital mortality (MICE, 0.67; Rice, 0.67; modified, 0.66; and Severinghaus, 0.66) than the missing-as-normal technique. Model calibration for in-hospital mortality was less precise for the missing-as-normal technique than for the other substitution techniques at the lower range of SOFA and among the subgroups. Conclusions: Using physiologic and statistical substitution methods improved the total SOFA score’s ability to discriminate mortality compared with the missing-as-normal technique. Treating missing data as normal may result in underreporting the severity of illness compared with using substitution. The simplicity of a direct oxygen saturation as measured by pulse oximetry/Fi O2 ratio–modified SOFA technique makes it an attractive choice for electronic health record–based research. This knowledge can inform comparisons of severity of illness across studies that used different techniques.

1 September 2025 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Closed access
EKEleni Kallinos
Eleni Kallinos
KCKuei-Pin Chung
Kuei-Pin Chung
LTLisa K. Torres
Lisa K. Torres
Divya BhatiaDivya Bhatia
Divya Bhatia
BEBaran Ersoy
Baran Ersoy
MPMaria Plataki
Maria Plataki
High-fat diet obesity is linked to increased lung injury and bronchoalveolar lavage fluid (BALF) fatty acids in a hyperoxic ARDS model. In the present study, obesity not only upregulated intracellular lipids and effectors of fatty acid mitochondrial import but also was associated with downregulated fatty acid oxidation and reduced ATP production in alveolar epithelial type 2 cells after injury. Hyperoxic AEC2 from obese mice had reduced phospholipids, and obese mice had increased BALF surface tension after injury.